LTB4R2 and neoplasm: Recently, we found that BLT2-KO suppresses KrasG12D-driven lung inflammation, IL-6 production, and tumor formation in a KrasG12D/BLT2-KO double-mutant mouse model compared to KrasG12D mice (Jang et al., 2021).